Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study

MLA

Severin Bausch, et al. “Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus Aureus Infections: A Prospective Cohort Study.” Antibiotics, vol. 13, no. 10, Sept. 2024, p. 928. EBSCOhost, https://doi.org/10.3390/antibiotics13100928.

APA

Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, Adrian Egli, Stephan Moser, Vladimira Hinic, Richard Kuehl, Stefano Bassetti, Martin Siegemund, Katharina M. Rentsch, Laura Hermann, Verena Schöning, Felix Hammann, Parham Sendi, & Michael Osthoff. (2024). Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study. Antibiotics, 13(10), 928. https://doi.org/10.3390/antibiotics13100928

Chicago

Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, Adrian Egli, Stephan Moser, Vladimira Hinic, Richard Kuehl, et al. 2024. “Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus Aureus Infections: A Prospective Cohort Study.” Antibiotics 13 (10): 928. doi:10.3390/antibiotics13100928.